Antibiotic resistance mechanisms in bacteria: Biochemical and genetic aspects

Food Technology and Biotechnology

Volumn 46, Issue 1, 2008, Pages 11-21

  Džidić, Senka ^a   Šušković, Jagoda ^b   Kos, Blaženka ^b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Antibiotic inactivation; Antibiotic resistance; Drug efflux; Horizontal gene transfer; Hypermutators; Membrane permeability changes; Multidrug resistance; Target modification

Indexed keywords

ANTIBIOTIC RESISTANCE; DRUG EFFLUX; HORIZONTAL GENE TRANSFER; HYPERMUTATORS; MEMBRANE PERMEABILITY; MULTIDRUG RESISTANCE; TARGET MODIFICATION;

BACTERIA; BIOLOGY; DRUG THERAPY; GENE TRANSFER; GENES;

ANTIBIOTICS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 44449086040     PISSN: 13309862     EISSN: 13342606     Source Type: Journal    
DOI: None     Document Type: Article

References (151)

1. D.M. Livermore, Bacterial resistance: Origins, epidemiology and impact, Clin. Infect. Dis. 36 (2003) 11-23.
2. J. Davies, Inactivation of antibiotics and the dissemination of resistance genes, Science, 264 (1994) 375-382.
3. F.C. Tenover, Development and spread of bacterial resistance to antimicrobial agents: An overview, Clin. Infect. Dis. (Suppl), 33 (2001) 108-115.
4. I.N. Okeke, K.P. Klugman, Z.A. Bhutta, A.G. Duse, P. Jenkins, T.F. O'Brien, A. Pablos-Mendez, R. Laxminarayan, Antimicrobial resistance in developing countries. Part II: Strategies for containment, Lancet Infect. Dis. 5 (2005) 568-580.
5. T. Barbosa, S.B. Levy, The impact of antibiotic use on resistance development and persistence, Drug Resist. Update, 3 (2000) 303-311.
6. S.E. Feinman, Antibiotics in animal feed, drug resistance revisited, ASM News, 64 (1998) 24-30.
7. B.T. Blackman, Resistant bacteria in retail meats and antimicrobial use in animals, New Engl. J. Med. 346 (2002) 777-779.
8. F.J. Angulo, N.L. Baker, S.J. Olsen, A. Anderson, T.J. Barrett, Antimicrobial use in agriculture: Controlling the transfer of antimicrobial resistance to humans, Semin. Pediatr. Infect. Dis. 15 (2004) 78-85.
9. A. Reilly, F. Kaeferstein, Food safety hazards and the application of the principles of the hazard analysis and critical control point (HACCP) system for their control in aquaculture production, Aquacult. Res. 28 (1997) 735-752.
10. The medical impact of the use of antimicrobials in food animals, Report of a WHO Meeting, WHO, Berlin, Germany (1997).
11. H.C Wegener, Antibiotics in animal feed and their role in resistance development, Curr. Opin. Microbiol. 6 (2003) 439-445.
12. V. Perreten, F. Schwarz, L. Cresta, M. Boeglin, G. Dasen, M. Teuber, Antibiotic resistance spread in food, Nature, 389 (1997) 801-802.
13. M. Teuber, L. Meile, F. Schwarz, Acquired antibiotic resistance in lactic acid bacteria from food, Antonie van Leeuwenhoek, 76 (1999) 115-137.
14. J. Šušković, B. Kos, S. Matošić, V. Marić, Probiotic properties of Lactobacillus plantarum L4, Food Technol. Biotechnol. 35 (1997) 107-112.
15. J. Šušković, B. Brkić, S. Matošić, V. Marić, Lactobacillus acidophilus M92 as potential probiotic strain, Milchwissenschaft, 52 (1997) 430-135.
16. S. Mathur, R. Singh, Antibiotic resistance in food lactic acid bacteria - A review, int. J. Food Microbiol. 105 (2005) 281-295.
17. A.A. Salyers, A. Gupta, Y. Wang, Human intestinal bacteria as reservoirs for antibiotic resistance genes, Trends Microbiol. 12 (2004) 412-416.
18. J. Davison, Genetic exchange between bacteria in the environment, Plasmid, 42 (1999) 73-91.
19. M.G. Kidwell, D.R. Lisch, Transposable elements and host genome evolution, Trends Ecol. Evol. 15 (2000) 95-99.
20. H. Ochman, J.G. Lawrence, E.A. Groisman, Lateral gene transfer and the nature of bacterial innovation, Nature, 405 (2000) 299-304.
21. B.B. Finlay, S. Falkow, Common themes in microbial pathogenicity revisited, Microbiol. Mol. Biol. Rev. 61 (1997) 136-169.
22. A. Manges, J. Johnson, B. Foxman, T.T. O'Bryan, K.E. Fullerton, L.W. Riley, Widespread distribution of urinary tract infections caused by a multi-drug resistant E. coli clonal group, New Engl. J. Med. 345 (2001) 1055-1057.
23. S. Dzidic, V. Bedekovic, Horizontal gene transfer-emerging multidrug resistance in hospital bacteria, Acta Pharmacol. Sin. 24 (2003) 519-226.
24. A.O. Summers, Genetic linkage and horizontal gene transfer, the roots of the antibiotic multi-resistance problem, Anim. Biotechnol. 17 (2006) 125-135.
25. R.V. Tauxe, S.D. Holmberg, M.L. Cohen: The Epidemiology of Gene Transfer in the Environment. In: Gene Transfer in the Environment, S.B. Levy, R.V. Miller (Eds.), McGraw-HiIl, New York, USA (1992) pp. 377-403.
26. Mechanisms of Action of Antibiotics and Mycotoxins. In: Bioactive Secondary Metabolites of Microorganisms, V. Betina (Ed.), Elsevier Science, Amsterdam, The Netherlands (1994) pp. 297-375.
27. Understanding Antibacterial Action and Resistance, A.D. Russell, I. Chopra (Eds.), Ellis Horwood, Hertfordshire, UK (1996).
28. J.A. Sutcliffe, J.P. Mueller, E.A. Utt: Antibiotic Resistance Mechanisms of Bacterial Pathogens. In: Manual of Industrial Microbiology and Biotechnology, A.L. Demain, J.E. Davies (Eds.), ASM Press, Washington, USA (1999) pp. 759-775.
29. W.R. Strohl: Biotechnology of Antibiotics, Marcel Dekker Inc., New York, USA (1997).
30. B. Benton, E. Breukink, I. Visscher, D. Debabov, C. Lunde, J. Jane, M. Mammen, P. Humphrey, Telavancin inhibits peptidoglycan biosynthesis through preferential targeting of transglycosylation: Evidence for a multivalent interaction between telavancin and lipid II, Int. J. Antimicrob. Agents (Suppl.), 29 (2007) 51-52.
31. K.L. Leach, S.M. Swaney, J.R. Colca, W.G. McDonald, J.R. Blinn, L.M. Thomasco, R.C. Gadwood, D. Shinabarger, L. Xiong, A.S. Mankin, The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria, Mol. Cell, 26 (2007) 393-102.
32. F.C. Tenover, Mechanisms of antimicrobial resistance in bacteria, Am. J. Med. (Suppl.), 229 (2006) 3-10.
33. S.K. Straus, R.E.W. Hancock, Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: Comparison with cationic antimicrobial peptides and lipopeptides, Biochim. Biophys. Acta, 1758 (2006) 1215-1223.
34. S. Mobashery, E.R Azucena: Bacterial Antibiotic Resistance. In: Encyclopedia of Life Sciences, Nature Publishing Group, London, UK (1999) (http://www.els.net).
35. C. Walsh, Molecular mechanisms that confer antibacterial drug resistance, Nature, 406 (2000) 775-781.
36. G.D. Wright, Bacterial resistance to antibiotics: Enzymatic degradation and modification, Adv. Drug Deliv. Rev. 57 (2005) 1451-1470.
37. P.A. Lambert, Bacterial resistance to antibiotics: Modified target sites, Adv. Drug Deliv. Rev. 57 (2005) 1471-1485.
38. A. Kumar, H.P. Schweizer, Bacterial resistance to antibiotics: Active efflux and reduced uptake, Adv. Drug Deliv. Rev. 57 (2005) 1486-1513.
39. C.T. Happi, G.O. Gbotosho, O.A. Folarin, D.O. Akinboye, B.O. Yusuf, O.O. Ebong, A. Sowunmi, D.E. Kyle, W. Milhous, D.T. Wirth, A.M.J. Oduola, Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfaxine-pyrimethamine resistance in malaria-infected patients from Nigeria, Acta Tropica, 95 (2005) 183-193.
40. L.P. Kotra, S. Mobashery, Mechanistic and clinical aspects of β-lactam antibiotics and β-lactamases, Arch. Immunol. Ther. Exp. (Warsaw), 47 (1999) 211-216.
41. K. Poole, Resistance to β-lactam antibiotics, Cell. Mol. Life Sci. 61 (2004) 2200-2223.
42. K. Bush, G.A. Jacoby, A.A. Medeiros, A functional classification scheme for ß-lactamases and its correlation with molecular structure, Antimicrob. Agents Chemother. 39 (1995) 1211-1233.
43. R. Bonnet, Growing group of extended-spectrum beta-lactamases: The CTX-M enzymes, Antimicrob. Agents Chemother. 48 (2004) 1-14.
44. P.A. Bradford, Extended-spectrum β-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat, Clin. Microbiol. Rev. 14 (2001) 933-951.
45. A.A. Shah, F. Hasan, S. Ahmed, A. Hameed, Extended-spectrum β-lactamases (ESBLs): Characterization, epidemiology and detection, Crit. Rev. Microbiol. 30 (2004) 25-32.
46. Amino Acid Sequences for TEM, SHV and OXA Extended-Spectrum and Inhibitor Resistant β-Lactamases (http://www.lahey.org/Studies/).
47. Y.H. Kim, C.J. Cha, C.E. Cerniglia, Purification and characterization of an erythromycin esterase from an erythromycin-resistant Pseudomonas sp., FEMS Microbiol. Lett. 210 (2002) 239-244.
48. A. Nakamura, K. Nakazawa, I. Miyakozawa, S. Mizukoshi, K. Tsurubuchi, M. Nakagawa, K. O'Hara, T. Sawai, Macrolide esterase-producing Escherichia coli clinically isolated in Japan, J. Antibiot. (Tokyo), 53 (2000) 516-524.
49. K.L. Fillgrove, S. Pakhomova, M.E. Newcomer, R.N. Armstrong, Mechanistic diversity of fosfomycin resistance in pathogenic microorganisms, J. Am. Chem. Soc. 125 (2003) 15730-15731.
50. M.W. Vetting, S. Magnet, E. Nieves, S.L. Roderick, J.S. Blanchard, A bacterial acetyltransferase capable of regioselective N-acetylation of antibiotics and histones, Chem. Biol. 11 (2004) 565-573.
51. S. Schwarz, C. Kehrenberg, B. Doublet, A. Cloeckaert, Molecular basis of bacterial resistance to chloramphenicol and florfenicol, FEMS Microbiol. Rev. 28 (2004) 519-542.
52. J. Allignet, N. El Solh, Diversity among the Gram-positive acetyltransferases inactivating streptogramin A and structurally related compounds and characterization of a new staphylococcal determinant, vatB, Antimicrob. Agents Chemother. 39 (1995) 2027-2036.
53. K. Yazawa, Y. Mikami, A. Maeda, N. Morisaki, S. Iwasaki, Phosphorylative inactivation of rifampicin by Nocardia otitidiscaviarum, J. Antimicrob. Chemother. 33 (1994) 1127-1135.
54. A. Nakamura, I. Miyakozawa, K. Nakazawa, O.H.K.T. Sawai, Detection and characterization of a macrolide 2′-phosphotransferase from Pseudomonas aeruginosa clinical isolate, Antimicrob. Agents Chemother. 44 (2000) 3241-3242.
55. M. Matsuoka, T. Sasaki, Inactivation of macrolides by producers and pathogens, Curr. Drug Targets Infect. Disord. 4 (2004) 217-240.
56. L.C. Pedersen, M.M. Benning, H.M. Holden, Structural investigation of the antibiotic and ATP-binding sites in kanamycin nucleotidyltransferase, Biochemistry, 34 (1995) 13305-13311.
57. A. Brisson-Noel, P. Delrieu, D. Samain, P. Courvalin, Inactivation of lincosaminide antibiotics in Staphylococcus. Identification of lincosaminide O-nucleotidyltransferases and comparison of the corresponding resistance genes, J. Biol. Chem. 263 (1988) 15880-15887.
58. A.T. Houang, Y.W. Chu, W.S. Lo, K.Y. Chu, A.F. Cheng, Epidemiology of rifampin ADP-ribosyltransferase (arr-2) and metallo-β-lactamase (blaIMP-4) gene cassettes in class 1 integrons in Acinetobacter strains isolated from blood cultures in 1997 to 2000, Antimicrob. Agents Chemother. 47 (2003) 1382-1390.
59. W. Yang, I.R Moore, K.P. Koteva, D.C. Bareich, D.W. Hughes, G.D. Wright, TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics, J. Biol. Chem. 279 (2004) 52346-52352.
60. F.P. Guengerich, Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity, Chem. Res. Toxicol. 14 (2001) 611-650.
61. S.J. Andersen, S. Quan, B. Gowan, E.R. Dabbs, Monooxygenase-like sequence of a Rhodococcus equi gene conferring increased resistance to rifampin by inactivating this antibiotic, Antimicrob. Agents Chemother. 41 (1997) 218-221.
62. B.G. Spratt, Resistance to antibiotics mediated by target alterations, Science, 264 (1994) 388-393.
63. M.C. Enright, The evolution of a resistant pathogen - The case of MRSA, Curr. Opin. Pharmacol. 3 (2003) 474-479.
64. T.A. Leski, A. Tomasz, Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: Evidence for the cooperative functioning of PBP2, PBP4, and PBP2A, J. Bacteriol. 187 (2005) 1815-1824.
65. K. Nagai, T.A. Davies, M.R. Jacobs, P.C. Appelbaum, Effects of amino acid alterations in penicillin-binding proteins (PBPs) la, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci, Antimicrob. Agents Chemother. 46 (2002) 1273-1280.
66. K. Kosowska, M.R. Jacobs, S. Bajaksouzian, L. Koeth, P.C. Appelbaum, Alterations of penicillin-binding proteins IA, 2X, and 2B in Streptococcus pneumoniae isolates for which amoxicillin MICs are higher than penicillin MICs, Antimicrob. Agents Chemother. 48 (2004) 4020-1022.
67. C.G. Dowson, T.J. Coffey, B.G. Spratt, Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to β-lactam antibiotics, Trends Microbiol. 2 (1994) 361-366.
68. K. Hiramatsu, Vancomycin-resistant Staphylococcus aureus: A new model of antibiotic resistance, Lancet Infect. Dis. 1 (2001) 147-155.
69. F.C. Tenover, M.V. Lancaster, B.C. Hill, C.D. Steward, S.A. Stocker, G.A. Hancock, C.M. O'Hara, S.K. McAllister, N.C. Clark, K. Hiramatsu, Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides, J. Clin. Microbiol. 36 (1998) 1020-1027.
70. M.A. Cooper, M.T. Fiorini, C. Abell, D.H. Williams, Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers, Bioorg. Med. Chem. 8 (2000) 2609-2616.
71. P. Courvalin, Genetics of glycopeptide resistance in Gram-positive pathogens, inf. J. Med. Microbiol. 294 (2005) 479-486.
72. B. Weisblum, Macrolide resistance, Drug Resist. Update, 1 (1998) 29-41.
73. B) resistance determinant in strains of Clostridium difficile, Microb. Drug Resist. 8 (2002) 45-53.
74. G. Ackermann, A. Degner, S.H. Cohen, J. Silva Jr., A.C. Rodloff, Prevalence and association of macrolide-lincosamide-streptogramin B (MLSB) resistance with resistance to moxifloxacin in Clostridium difficile, J. Antimicrob. Chemother. 51 (2003) 599-603.
75. B. Weisblum, Erythromycin resistance by ribosome modification, Antimicrob. Agents Chemother. 39 (1995) 577-585.
76. A. Canu, B. Malbruny, M. Coquemont, T.A. Davies, P.C. Appelbaum, R. Leclercq, Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae, Antimicrob. Agents Chemother. 46 (2002) 125-131.
77. B. Bozdogan, P.C. Appelbaum, Oxazolidinones: Activity, mode of action, and mechanism of resistance, Int. J. Antimicrob. Agents, 23 (2004) 113-119.
78. G. Wang, D.E. Taylor, Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics, Antimicrob. Agents Chemother. 42 (1998) 1952-1958.
79. Y. Suzuki, C. Katsukawa, A. Tamaru, C. Abe, M. Makino, Y. Mizuguchi, H. Taniguchi, Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene, J. Clin. Microbiol. 36 (1998) 1220-1225.
80. G. Maravić Vlahoviček, S. Čubrilo, K.L. Tkaczuk, J.M. Bujnicki, Modeling and experimental analyses reveal a two-domain structure and amino acids important for the activity of aminoglycoside resistance methyltransferase Sgm, Biochim. Biophys. Acta (in press).
81. A.B. Khodursky, E.L. Zechiedrich, N.R. Cozzarelli, Topoisomerase IV is a target of quinolones in Escherichia coli, Proc. Natl. Acad. Sci. USA, 92 (1995) 11801-11805.
82. D. Ince, X. Zhang, L.C. Silver, D.C. Hooper, Dual targeting of DNA gyrase and topoisomerase IV: Target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone, Antimicrob. Agents Chemother. 46 (2002) 3370-3380.
83. C.J. Willmott, A. Maxwell, A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex, Antimicrob. Agents Chemother. 37 (1993) 126-127.
84. D.C. Hooper, Mechanisms of fluoroquinolone resistance, Drug Resist. Update, 2 (1999) 38-55.
85. G.M. Eliopoulos, Quinolone resistance mechanisms in pneumococci, Clin. Infect. Dis. (Suppl), 38 (2004) 350-356.
86. H. Nikaido, Prevention of drug access to bacterial targets: Permeability barriers and active efflux, Science, 264 (1994) 382-388.
87. H. Nikaido, H.I. Zgurskaya, Antibiotic efflux mechanisms, Curr. Opin. Infect. Dis. 12 (1999) 529-536.
88. M.A. Webber, L.J. Piddock, The importance of efflux pumps in bacterial antibiotic resistance, J. Antimicrob. Chemother. 51 (2003) 9-11.
89. H.W. van Veen, W.N. Konings, Drug efflux proteins in multidrug resistant bacteria, Biol. Chem. 378 (1997) 769-777.
90. K. Poole, Multidrug efflux pumps and antimicrobial resistance in P. aeruginosa and related organisms, J. Mol. Microbiol. Biotechnol. 3 (2001) 225-264.
91. N. Gotoh, H. Tsujimoto, K. Poole, J. Yamagishi, T. Nishino, The outer membrane protein OprM of Pseudomonas aeruginosa is encoded by oprK of the mexA-mexB-oprK multidrug resistance Operon, Antimicrob. Agents Chemother. 39 (1995) 2567-2569.
92. T. Köhler, S.R Epp, L.K. Curty, J.C. Pechère, Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa, J. Bacterial. 181 (1999) 6300-6305.
93. K.P. Langton, P.J.R Henderson, R.B. Herbert, Antibiotic resistance: Multidrug efflux proteins, a common transport mechanism?, Nat. Prod. Rep. 22 (2005) 439-451.
94. M. Putman, H.W van Veen, W.N. Konings, Molecular properties of bacterial multidrug transporters, Microbiol. Mol. Biol. Rev. 64 (2000) 672-693.
95. S.S. Pao, I.T. Paulsen, M.H. Saier Jr., Major facilitator superfamily, Microbiol. Mol. Biol. Rev. 62 (1998) 1-34.
96. H.W. van Veen, W.N. Konings, The ABC family of multidrug transporters in microorganisms, Biochim. Biophys. Acta, 1365 (1998) 31-36.
97. H. Okusu, D. Ma, H. Nikaido, AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escnerichia coli multiple-antibiotic- resistance (Mar) mutants, J. Bacterial. 178 (1996) 306-308.
98. M.J. Fath, R. Kolter, ABC transporters: Bacterial exporters, Microbiol. Rev. 57 (1993) 995-1017.
99. C. Ma, G. Chang, Structure of the multidrug resistance efflux transporter EmrE from Escherichia coli, Proc. Natl. Acad. Sci. USA, 101 (2004) 2852-2857.
100. H. Nikaido, Molecular basis of bacterial outer membrane permeability revisited, Microbiol. Mol. Biol. Rev. 67 (2003) 593-656.
101. S.P. Denyer, J.Y. Maillard, Cellular impermeability and uptake of biocides and antibiotics in Gram-negative bacteria, J. Appl. Microbiol. (Suppl.) 92 (2002) 35-45.
102. J. Chevalier, J.M. Pages, M. Mallea, In vivo modification of porin activity conferring antibiotic resistance to Enterobacter aerogenes, Biochem. Biophys. Res. Commun. 266 (1999) 248-251.
103. E. Dé, A. Baslé, M. Jaquinod, N. Saint, M. Malléa, G. Molle, J.M. Pages, A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin, Mol. Microbiol. 41 (2001) 189-198.
104. R.E. Hancock, F.S. Brinkman, Function of Pseudomonas porins in uptake and efflux, Annu. Rev. Microbiol. 56 (2002) 17-38.
105. A. Wiese, K. Brandenburg, A.J. Ulmer, U. Seydel, S. Müller-Loennies, The dual role of lipopolysaccharide as effector and target molecule, Biol. Chem. 380 (1999) 767-784.
106. M. Vaara, Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in Gram-negative enteric bacteria, Antimicrob. Agents Chemother. 37 (1993) 354-356.
107. R.I. Aminov, R.I. Mackie, Evolution and ecology of antibiotic resistance genes, FEMS Microbiol. Lett. 271 (2007) 147- 161.
108. R. Krašovec, I. Jerman, Bacterial multicellularity as a possible source of antibiotic resistance, Med. Hypotheses, 60 (2003) 484-188.
109. N. Woodford, M.J. Ellington, The emergence of antibiotic resistance by mutation, Clin. Microbiol. Infect. 13 (2007) 5-18.
110. D.C. Hooper, Mechanisms of fluoroquinolone resistance, Drug Resist. Update, 2 (1999) 38-55.
111. S. Nakamura, M. Nakamura, T. Kojima, H. Yoshida, gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli, Antimicrob. Agents Chemother. 33 (1989) 254-255.
112. J.L. Martinez, F. Baquero, Mutation frequencies and antibiotic resistance, Antimicrob. Agents Chemother. 44 (2000) 1771-1777.
113. J. Ruiz, Mechanisms of resistance to quinolones: Target alterations, decreased accumulation and DNA gyrase protection, J. Antimicrob. Chemother. 51 (2003) 1109-1117.
114. D.J. Wolter, N.D. Hanson, P.D. Lister, Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance, FEMS Microbiol. Lett. 236 (2004) 137-143.
115. F. Depardieu, I. Podglajen, R. Leclercq, E. Collatz, P. Courvalin, Modes and modulations of antibiotic resistance gene expression, Clin. Microbiol. Rev. 20 (2007) 79-114.
116. L.J. Piddock, Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria, Clin. Microbiol. Rev. 19 (2006) 382-402.
117. T.M. Barbosa, S.B. Levy, Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA, J. Bacterwl. 182 (2000) 3467-3474.
118. L. Adewoye, A. Sutherland, R. Srikumar, K. Poole, The mexR repressor of the mexAB-oprM multidrug efflux Operon in Pseudomonas aeruginosa: Characterization of mutations compromising activity, J. Bacteriol. 184 (2002) 4308-4312.
119. S. Rasmaswamy, J.M. Musser, Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update, Tuber. Lung Dis. 79 (1998) 3-29.
120. A. Oliver, R. Cantón, P. Campo, F. Baquero, J. Blázquez, High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection, Science, 288 (2000) 1251-1253.
121. R.M. Schaaper, Base selection, proofreading, and mismatch repair during DNA replication in Escherichia coli, J. Biol. Chem. 268 (1993) 23762-23765.
122. J.W. Drake, B. Charlesworth, D. Charlesworth, F. James, Rates of spontaneous mutation, Genetics, 148 (1998) 1667-1686.
123. E. Denamur, S. Bonacorsi, A. Giraud, P. Duriez, F. Hilali, C. Amorin, E. Bingen, A. Andremont, B. Picard, F. Taddei, I. Matic, High frequency of mutator strains among human uropathogenic Escherichia coli isolates, J. Bacterial. 184 (2002) 605-609.
124. J.E. LeClerc, B. Li, W.L. Payne, T.A. Cebula, High mutation frequencies among Escherichia coli and Salmonella pathogens, Science, 274 (1996) 1208-1211.
125. J.R Horst, T. Wu, M.G. Marinus, Escherichia coli mutator genes, Trends Microbiol. 7 (1999) 29-36.
126. B.D. Harfe, S. Jinks-Robertson, DNA mismatch repair and genetic instability, Annu. Rev. Genet. 34 (2000) 359-399.
127. A. Oliver, F. Baquero, J. Blázquez, The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: Molecular characterization of naturally occurring mutants, Mol. Microbiol. 43 (2002) 1641-1650.
128. C. Rayssiguier, D.S. Thaler, M. Radman, The barrier to recombination between Escherichia coli and Salmonella typhimurium is disrupted in mismatch-repair mutants, Nature, 342 (1989) 396-101.
129. A. Giraud, I. Matic, M. Radman, M. Fons, F. Taddei, Mutator bacteria as a risk factor in treatment of infectious diseases, Antimicrob. Agents Chemother. 46 (2002) 863-865.
130. I. Chopra, A.J. O'Neill, K. Miller, The role of mutators in the emergence of antibiotic-resistant bacteria, Drug Resist. Update, 6 (2003) 137-145.
131. J. Blázquez, Hypermutation as a factor contributing to the acquisition of antimicrobial resistance, Clin. Infect. Dis. 37 (2003) 1201-1209.
132. M.D. Macia, D. Blanquer, B. Togores, J. Sauleda, J.L. Perez, A. Oliver, Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections, Antimicrob. Agents Chemother. 49 (2005) 3382-3386.
133. F. Taddei, M. Radman, J. Maynard-Smith, B. Toupance, P.H. Gouyon, B. Godelle, Role of mutator alleles in adaptive evolution, Nature, 387 (1997) 700-702.
134. I. Bjedov, O. Tenaillon, B. Gerard, V. Souza, E. Denamur, M. Radman, F. Taddei, I. Matic, Stress-induced mutagenesis in bacteria, Science, 300 (2003) 1404-1409.
135. W.A. Rosche, P. Foster: Mutation Under Stress: Adaptive Mutation in Escherichia coli. In: Bacterial Stress Responses, G. Storz, R. Hengge-Aronis (Eds.), ASM Press, Washington DC, USA (2000).
136. M.D. Sutton, B.T. Smith, V.G. Godoy, G.C. Walker, The SOS response: Recent insights into umuDC-dependent mutagenesis and DNA damage tolerance, Annu. Rev. Genet. 34 (2000) 479-497.
137. L.J. Piddock, R. Wise, Induction of the SOS response in Escherichia coli by 4-quinolone antimicrobial agents, FEMS Microbiol. Lett. 41 (1987) 289-294.
138. P. Ysern, B. Clerch, M. Castaño, I. Gilbert, J. Barbé, M. Llagostera, Induction of SOS genes in Escherichia coli and mutagenesis in Salmonella typhimurium by fluoroquinolones, Mutagenesis, 5 (1990) 63-66.
139. L. Ren, M.S. Rahman, M.Z. Humayun, Escherichia coli cells exposed to streptomycin display a mutator phenotype, J. Bactenol. 282 (1999) 1043-1044.
140. M.C. Roberts, Tetracycline and MLS nomenclature (http://faculty. washington.edu/marilynr/).
141. M.C. Roberts, Update on acquired tetracycline resistance genes, FEMS Microbiol. Lett. 245 (2005) 195-203.
142. A.A. Salyers, K. Moon, D. Schlesinger, The human intestinal tract - A hotbed of resistance gene transfer?, Part I, Clin. Microbiol. Newslett. 29 (2007) 17-21.
143. S. Simjee, M.J. Gill, Gene transfer, gentamicin resistance and enterococci, J. Hosp. Infect. 36 (1997) 249-259.
144. D.A. Rowe-Magnus, D. Mazel, Resistance gene capture, Curr. Opin. Microbiol. 2 (1999) 483-188.
145. M.C. Ploy, T. Lambert, J.R Couty, F. Denis, Integrons: An antibiotic resistance gene capture and expression system, Clin. Chem. Lab. Med. 38 (2000) 483-187.
146. Y. Boucher, M. Labbate, J.E. Koenig, H.W. Stokes, Integrons: Mobilizable platforms that promote genetic diversity in bacteria, Trends Microbiol. 25 (2007) 301-309.
147. B.G. Spratt, L.D. Bowler, Q.Y. Zhang, J. Zhou, J.M. Smith, Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species, J. Mol. Evol. 34 (1992) 115-125.
148. W. Nirdnoy, C.J. Mason, P. Guerry, Mosaic structure of a multiple-drug-resistant, conjugative plasmid from Campylobacter jejuni, Antimicrob. Agents Chemother. 49 (2005) 2454-2459.
149. S. Džidić, V. Bačun-Družina, M. Petranović, The role of mismatch repair in bacterial evolution, Food Technol. Biotechnol. 41 (2003) 177-182.
150. M. Vulic, F. Dionisio, F. Taddei, M. Radman, Molecular keys to speciation: DNA polymorphism and the control of genetic exchange in enterobacteria, Proc. Natl. Acad. Sci. USA, 94 (1997) 9763-9767.
151. B.H. Normark, S. Normark, Evolution and spread of antibiotic resistance, J. Intern. Med. 252 (2002) 91-106.